Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug:77:102230.
doi: 10.1016/j.coi.2022.102230. Epub 2022 Jul 8.

Adaptive immune responses to Kaposi's sarcoma-associated herpesvirus

Angela Nalwoga  1 , Denise Whitby  2
Affiliations
Review

Adaptive immune responses to Kaposi's sarcoma-associated herpesvirus

Angela Nalwoga et al. Curr Opin Immunol. 2022 Aug.

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is a gammaherpesvirus that causes Kaposi's sarcoma (KS), primary effusion lymphoma, multicentric Castleman's disease and KSHV-induced cytokine syndrome. KSHV established lifelong infection and has evolved numerous ways in which to evade adaptive immune responses. Most KSHV infections are asymptomatic but when disease occurs it does so in the context of immune suppression especially HIV infection. It is important therefore to study immune responses to KSHV in order to understand KSHV-related disease pathogenesis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: none

References

    1. Areste C, Blackbourn DJ: Modulation of the immune system by Kaposi’s sarcoma-associated herpesvirus. Trends Microbiol 2009, 17:119–129. - PubMed
    1. Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler J, Newton R, Rinaldo CR, Saah A, Phair J, et al.: KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi’s sarcoma. Nat Med 1996, 2:925–928. - PubMed
    1. Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, Rainbow L, Howard MR, Gao SJ, Bohenzky RA, Simmonds P, et al.: Prevalence of Kaposi’s sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996, 348:1133–1138. - PubMed
    1. Kedes DH, Ganem D, Ameli N, Bacchetti P, Greenblatt R: The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma- associated herpesvirus) among HIV-seropositive and high-risk HIV- seronegative women. Jama 1997, 277:478–481. - PubMed
    1. Mbisa GL, Miley W, Gamache CJ, Gillette WK, Esposito D, Hopkins R, Busch MP, Schreiber GB, Little RF, Yarchoan R, et al.: Detection of antibodies to Kaposi’s sarcoma-associated herpesvirus: a new approach using K8.1 ELISA and a newly developed recombinant LANA ELISA. J Immunol Methods 2010, 356:39–46. - PMC - PubMed

Publication types